Metabolomic Profiling of Bipolar Disorder by 1H-NMR in Serbian Patients
Authors:
- Katarina SimićKSKatarina Simić
- Zoran MiladinovićZMZoran Miladinović
- Nina TodorovićNTNina Todorović
- Snežana TrifunovićSTSnežana Trifunović
- Nataša AvramovićNANataša Avramović
- Aleksandra GavrilovićAGAleksandra Gavrilović
- Silvana JovanovićSJSilvana Jovanović
- Dejan GođevacDejan Gođevac
- Ljubodrag VujisićLjubodrag Vujisić
- Vele TeševićVTVele Tešević
- Ljubica TasicLTLjubica Tasic
- Boris MandićBMBoris Mandić
Open Access
- 28 April 2023
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 13 (5) , 607
Abstract
Bipolar disorder (BD) is a brain disorder that causes changes in a person’s mood, energy, and ability to function. It has a prevalence of 60 million people worldwide, and it is among the top 20 diseases with the highest global burden. The complexity of this disease, including diverse genetic, environmental, and biochemical factors, and diagnoses based on the subjective recognition of symptoms without any clinical test of biomarker identification create significant difficulties in understanding and diagnosing BD. A 1H-NMR-based metabolomic study applying chemometrics of serum samples of Serbian patients with BD (33) and healthy controls (39) was explored, providing the identification of 22 metabolites for this disease. A biomarker set including threonine, aspartate, gamma-aminobutyric acid, 2-hydroxybutyric acid, serine, and mannose was established for the first time in BD serum samples by an NMR-based metabolomics study. Six identified metabolites (3-hydroxybutyric acid, arginine, lysine, tyrosine, phenylalanine, and glycerol) are in agreement with the previously determined NMR-based sets of serum biomarkers in Brazilian and/or Chinese patient samples. The same established metabolites (lactate, alanine, valine, leucine, isoleucine, glutamine, glutamate, glucose, and choline) in three different ethnic and geographic origins (Serbia, Brazil, and China) might have a crucial role in the realization of a universal set of NMR biomarkers for BD.Keywords
Funding Information
- Organisation for the Prohibition of Chemical Weapons (OPCW) (L/ICA/ICB-217652/18, L/ICA/ICB-108/21, 451-03-68/2022-14/200168, 451-03-68/2022-14/200026, 451-03-47/2023-01/200051)
- Ministry of Education and Science of the Republic of Serbia (L/ICA/ICB-217652/18, L/ICA/ICB-108/21, 451-03-68/2022-14/200168, 451-03-68/2022-14/200026, 451-03-47/2023-01/200051)
This publication has 50 references indexed in Scilit:
- Bipolar disorder diagnosis: challenges and future directionsThe Lancet, 2013
- Optimized bucketing for NMR spectra: Three case studiesChemometrics and Intelligent Laboratory Systems, 2013
- Metabolic Profiling of Human Blood Serum from Treated Patients with Bipolar Disorder Employing 1H NMR Spectroscopy and ChemometricsAnalytical Chemistry, 2009
- Metabolomics tools for identifying biomarkers for neuropsychiatric diseasesNeurobiology of Disease, 2009
- Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitusAnalytica Chimica Acta, 2009
- Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorderMolecular Psychiatry, 2008
- Metabolomics: A Global Biochemical Approach to Drug Response and DiseaseAnnual Review of Pharmacology and Toxicology, 2008
- Visualization of GC/TOF-MS-Based Metabolomics Data for Identification of Biochemically Interesting Compounds Using OPLS Class ModelsAnalytical Chemistry, 2007
- Performance of some variable selection methods when multicollinearity is presentChemometrics and Intelligent Laboratory Systems, 2005
- Evaluation of the Orthogonal Projection on Latent Structure Model Limitations Caused by Chemical Shift Variability and Improved Visualization of Biomarker Changes in 1H NMR Spectroscopic Metabonomic StudiesAnalytical Chemistry, 2004